Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
PaperCitations, authors & open-access status
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 172 citations, 2023 year and hybrid oa status.
172
Citations
2023
Year
hybrid
OA Status